Spain – Various medicinal products – Suministro de los medicamentos FERRIPROX 500 mg comp, principio activo DEFERIPRONA
Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria awarded €81.3K to CHIESI ESPAÑA S.A. for Construction & Public Works in May 2024 — one of 94 awards this buyer has made, below its typical award size.
Winning supplier
CHIESI ESPAÑA S.A.Contract description
Spain – Various medicinal products – Suministro de los medicamentos FERRIPROX 500 mg comp, principio activo DEFERIPRONA y QUINSAIR 240 MG AMPOLLA INHALADA, principio activo LEVOFLOXACINO, con destino el Servicio de Farmacia del Hospital Universitario Ntra. Sra. de Candelaria.
Related awards · Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria
94 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-354025-2025WERFEN ESPAÑA, S.A.U.€652K02 Jun 2025 Construction
- ocds-ted-696051-2024KERN PHARMA, S.L.€561K15 Nov 2024 Construction
- ocds-ted-693178-2024Roche Farma, S.A.€553K14 Nov 2024 Construction
Other wins · CHIESI ESPAÑA S.A.
26 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-775573-2025OSAKIDETZA - Servicio Vasco de Salud - Organización Central€2.9M21 Nov 2025 Construction
- ocds-ted-608850-2025Servicio Navarro de Salud-Osasunbidea€791K17 Sep 2025 Construction
- ocds-ted-419783-2025OSAKIDETZA - Servicio Vasco de Salud - Organización Central€672K30 Jun 2025 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria and CHIESI ESPAÑA S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back